Related references
Note: Only part of the references are listed.EGFR Promotes Lung Tumorigenesis by Activating miR-7 through a Ras/ERK/Myc Pathway That Targets the Ets2 Transcriptional Repressor ERF
Yu-Ting Chou et al.
CANCER RESEARCH (2010)
A Phase II Study of Celecoxib in Combination with Paclitaxel, Carboplatin, and Radiotherapy for Patients with Inoperable Stage IIIA/B Non-Small Cell Lung Cancer
Robert Mutter et al.
CLINICAL CANCER RESEARCH (2009)
Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor status
Y. Akashi et al.
BRITISH JOURNAL OF CANCER (2008)
COX-2/EGFR expression and survival among women with adenocarcinoma of the lung
Alison L. Van Dyke et al.
CARCINOGENESIS (2008)
The potential predictive value of cyclooxygenase-2 expression and increased risk of gastrointestinal hemorrhage in advanced non-small cell lung cancer patients treated with erlotinib and celecoxib
Mary J. Fidler et al.
CLINICAL CANCER RESEARCH (2008)
Inflammation in lung carcinogenesis: New targets for lung cancer chemoprevention and treatment
Jay M. Lee et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells
Jen-Chung Ko et al.
MOLECULAR CANCER THERAPEUTICS (2008)
EGFR signaling is required for TGF-β1-Mediated COX-2 induction in human bronchial epithelial cells
Ming Liu et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
Integrating signals from RTKs to ERK/MAPK
M. M. McKay et al.
ONCOGENE (2007)
Mutation profile of EGFR gene detected by denaturing high-performance liquid chromatography in Japanese lung cancer patients
Naoko Sueoka et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2007)
Phase II study of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), and celecoxib, a cyclooxygenase-2 (COX-2) inhibitor, in patients with platinum refractory non-small cell lung cancer (NSCLC)
Shirish M. Gadgeel et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
Unraveling the mystery of prognostic and predictive factors in epidermal growth factor receptor therapy
FA Shepherd et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Critical update and emerging trends in epidermal growth factor receptor targeting in cancer
J Baselga et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Cyclooxygenase-2 protein levels are independent of epidermal growth factor receptor expression or activation in operable non-small cell lung cancer
CM Richardson et al.
LUNG CANCER (2005)
Interaction between epidermal growth factor receptor- and cyclooxygenase 2-mediated pathways and its implications for the chemoprevention of head and neck cancer
MS Choe et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Timeline - The discovery of receptor tyrosine kinases: targets for cancer therapy
A Gschwind et al.
NATURE REVIEWS CANCER (2004)
Drug therapy: Multidisciplinary management of lung cancer
A Spira et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
COX-2, MMP-9, and Noguchi classification provide additional prognostic information about adenocarcinoma of the lung - A study of 117 patients from Brazil
NH Yamaguchi et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2004)
The biology of epidermal growth factor receptor in lung cancer
GV Scagliotti et al.
CLINICAL CANCER RESEARCH (2004)
Epidermal growth factor receptor in non-small-cell lung carcinomas:: Correlation between gene copy number and protein expression and impact on prognosis
FR Hirsch et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Epidermal growth factor receptor: mechanisms of activation and signalling
RN Jorissen et al.
EXPERIMENTAL CELL RESEARCH (2003)
The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis
AP Meert et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44
M Dohadwala et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung
Y Hosomi et al.
LUNG CANCER (2000)
Cell signaling by receptor tyrosine kinases
J Schlessinger
CELL (2000)
Share Paper
